Dr. Andrew Eugene Bean, MD

Dr. Bean practices at San Antonio Eye Center, PA in San Antonio, Texas.

Dr. Bean's NPI, 1093202004, was assigned on April 16, 2018. Dr. Bean graduated from McGovern Medical School in 2018. Dr. Bean holds Texas license T5261.

Dr. Bean's primary practice is San Antonio Eye Center, PA, at 2119 Commercial Ave, San Antonio, TX 78221 in Bexar County. The practice phone is (210) 226-6169.

Dr. Bean's primary practice is San Antonio Eye Center, PA in San Antonio, Texas. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Bean to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bean practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Bean's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Bean is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Bean is licensed in Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, glaucoma, glaucoma surgery and inflammation of iris among the conditions Dr. Bean treats.

CMS data shows 770 Medicare services from Dr. Bean across 11 procedure codes in 2024, for 285 Medicare patients. Medicare paid $59,174 for them.

CMS counts 285 Medicare patients who saw Dr. Bean in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bean's median patient age at 69, with 58% women.

In 2024, Dr. Bean wrote 3,548 Medicare Part D claims for 942 patients. 68% of them were for generic drugs. CMS names the drug for 3,462 of them, across 19 drugs with 11 or more claims each, at $175,308 in total drug cost. In 2023, CMS named 1,250 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Bean for performance year 2024, reported as part of a group. Dr. Bean accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 110 procedures of cataract surgery by Dr. Bean, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Bean, published from 2017 to 2021. 2021 was the busiest year, with 2. Dr. Bean has published most often in Case Rep Ophthalmol Med. Dr. Bean's most frequent co-authors are Thomas F. Mauger, MD, Annahita Amireskandari, MD and Geoffrey E. Bradford, MD.

CMS Open Payments shows 73 general payments to Dr. Bean from 14 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 74% of the total. Abbvie Inc. paid the most, $1,872.

Dr. Bean graduated from McGovern Medical School in 2018.

Dr. Bean is in network with 27 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 17. Check the plan with the practice before a visit.